BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37104896)

  • 1. Computed tomography imaging features to evaluate the severity of portal hypertension and predict the rebleeding risk after endoscopic treatment in cirrhotic patients with variceal hemorrhage.
    Rao C; Chen J; Wang W; Xue C; Wu L; Huang X; Chen S; Rao S; Li F
    Eur J Radiol; 2023 Jun; 163():110841. PubMed ID: 37104896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study.
    Zheng J; Zhang Y; Li P; Zhang S; Li Y; Li L; Ding H
    BMC Gastroenterol; 2019 Feb; 19(1):32. PubMed ID: 30782139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical characteristics of advanced portal vein thrombosis in cirrhotic patients with gastroesophageal variceal hemorrhage.
    Rao CY; Xue CY; Fang QQ; Wu L; Huang XQ; Chen Y; Chen SY; Li F
    J Dig Dis; 2023 Apr; 24(4):284-292. PubMed ID: 37246244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis.
    Wu L; Fang QQ; Huang XQ; Xue CY; Rao CY; Luo JJ; Xu PJ; Chen Y; Chen S; Li F
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):301-308. PubMed ID: 36795329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation and treatment of portal hypertension].
    Brůha R; Petrtýl J
    Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg.
    Guo H; Zhang F; Yin X; Zhang M; Xiao J; Wang Y; Zhang B; Zhang W; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1427-1435. PubMed ID: 32868650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography perfusion in liver and spleen for hepatitis B virus-related portal hypertension: A correlation study with hepatic venous pressure gradient.
    Wang L; Zhang Y; Wu YF; Yue ZD; Fan ZH; Zhang CY; Liu FQ; Dong J
    World J Gastroenterol; 2022 Nov; 28(42):6068-6077. PubMed ID: 36405387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China.
    Shao R; Li Z; Wang J; Qi R; Liu Q; Zhang W; Mao X; Song X; Li L; Liu Y; Zhao X; Liu C; Li X; Zuo C; Wang W; Qi X
    BMJ Open; 2020 Jun; 10(6):e030960. PubMed ID: 32580978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
    Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
    Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis.
    Kim BH; Chung JW; Lee CS; Jang ES; Jeong SH; Kim N; Kim JW
    Korean J Intern Med; 2019 Nov; 34(6):1233-1243. PubMed ID: 30759966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of portal vein thrombosis on the efficacy of endoscopic treatment in preventing re-bleeding from ruptured gastroesophageal varices in hepatitis B-related liver cirrhosis].
    Huang XQ; Ni LY; Jiang SY; Xia RQ; Ma LL; Wang J; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):747-752. PubMed ID: 33053974
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage.
    Lee SW; Lee TY; Chang CS
    Dig Dis Sci; 2009 May; 54(5):1128-34. PubMed ID: 19051032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks.
    Zhou Y; Zhang W; Zhang Z; Luo J; Gu J; Liu Q; Ma J; Yan Z; Chen S; Wang J
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1235-1243. PubMed ID: 32744824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing liver cirrhotic complications: Overview of esophageal and gastric varices.
    Lesmana CRA; Raharjo M; Gani RA
    Clin Mol Hepatol; 2020 Oct; 26(4):444-460. PubMed ID: 33053928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative CT Predictors of Portal Venous Intervention in Uncontrolled Variceal Bleeding.
    Pham JT; Kalantari J; Ji C; Chang JH; Kiang SC; Jin DH; Tomihama RT
    AJR Am J Roentgenol; 2020 Nov; 215(5):1247-1251. PubMed ID: 32901570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current situation of screening, prevention and treatment of bleeding esophageal varices in cirrhotic portal hypertension in Tibet region: a multicenter study].
    Huan H; Liu C; Yang Z; Bao JL; Liu C; Wang JT; Zhang L; Wang CH; Ci RSP; Tu QL; Ren T; Xu D; Zhang HJ; Li XG; Kang N; Li XP; Wu YH; Pu X; Tan YJ; Cao JJ; Luo SWQ; Luo SQP; Zhuo M; Qi XL
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):737-741. PubMed ID: 33053972
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
    Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
    Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.